{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:31:08Z","timestamp":1793647868601,"version":"4.5.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010301","name":"Oral and Maxillofacial Surgery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["K23DE030250"],"award-info":[{"award-number":["K23DE030250"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA047063"],"award-info":[{"award-number":["R01DA047063"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA047820"],"award-info":[{"award-number":["R01DA047820"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Oral squamous cell carcinoma (OSCC) has poor survival rates. There is a pressing need to develop more precise risk assessment methods to tailor clinical treatment. Epigenome-wide association studies in OSCC have not produced a viable biomarker. These studies have relied on methylation array platforms, which are limited in their ability to profile the methylome. In this study, we use MethylCap-Seq (MC-Seq), a comprehensive methylation quantification technique, and brush swab samples, to develop a noninvasive, readily translatable approach to profile the methylome in OSCC patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Three OSCC patients underwent collection of cancer and contralateral normal tissue and brush swab biopsies, totaling 4 samples for each patient. Epigenome-wide DNA methylation quantification was performed using the SureSelectXT Methyl-Seq platform. DNA quality and methylation site resolution were compared between brush swab and tissue samples. Correlation and methylation value difference were determined for brush swabs vs. tissues for each respective patient and site (i.e.<jats:italic>,<\/jats:italic> cancer or normal). Correlations were calculated between cancer and normal tissues and brush swab samples for each patient to determine the robustness of DNA methylation marks using brush swabs in clinical biomarker studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were no significant differences in DNA yield between tissue and brush swab samples. Mapping efficiency exceeded 90% across all samples, with no differences between tissue and brush swabs. The average number of CpG sites with at least 10x depth of coverage was 2,716,674 for brush swabs and 2,903,261 for tissues. Matched tissue and brush swabs had excellent correlation (<jats:italic>r<\/jats:italic>\u2009=\u20090.913 for cancer samples and <jats:italic>r<\/jats:italic>\u2009=\u20090.951 for normal samples). The methylation profile of the top 1000 CpGs was significantly different between cancer and normal samples (mean <jats:italic>p<\/jats:italic>-value\u2009=\u20090.00021) but not different between tissues and brush swabs (mean <jats:italic>p<\/jats:italic>-value\u2009=\u20090.11).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results demonstrate that MC-Seq is an efficient platform for epigenome profiling in cancer biomarker studies, with broader methylome coverage than array-based platforms. Brush swab biopsy provides adequate DNA yield for MC-Seq, and taken together, our findings set the stage for development of a non-invasive methylome quantification technique for oral cancer with high translational potential.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40364-021-00349-x","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T09:02:51Z","timestamp":1639990971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Brush swab as a noninvasive surrogate for tissue biopsies in epigenomic profiling of oral cancer"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5078-7807","authenticated-orcid":false,"given":"Chi T.","family":"Viet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesava","family":"Asam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carissa M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas F.","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coleen","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Grandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint T.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Melville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Shum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan T.","family":"Viet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Herford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan F.","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel L.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang F.","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley E.","family":"Aouizerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"349_CR1","doi-asserted-by":"publisher","first-page":"i6369","DOI":"10.1136\/bmj.i6369","volume":"355","author":"A Gulland","year":"2016","unstructured":"Gulland A. Oral cancer rates rise by two thirds. BMJ. 2016;355:i6369. https:\/\/doi.org\/10.1136\/bmj.i6369.","journal-title":"BMJ"},{"key":"349_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.oraloncology.2017.02.019","volume":"67","author":"JE Tota","year":"2017","unstructured":"Tota JE, Anderson WF, Coffey C, Califano J, Cozen W, Ferris RL, et al. Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012. Oral Oncol. 2017;67:146\u201352. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.02.019.","journal-title":"Oral Oncol"},{"issue":"1","key":"349_CR3","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.1038\/s41598-020-64748-0","volume":"10","author":"YJ Kim","year":"2020","unstructured":"Kim YJ, Kim JH. Increasing incidence and improving survival of oral tongue squamous cell carcinoma. Sci Rep. 2020;10(1):7877. https:\/\/doi.org\/10.1038\/s41598-020-64748-0.","journal-title":"Sci Rep"},{"issue":"8","key":"349_CR4","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/hed.26089","volume":"42","author":"AJ Yoon","year":"2020","unstructured":"Yoon AJ, Wang S, Kutler DI, Carvajal RD, Philipone E, Wang T, et al. MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at high-risk for cancer-specific mortality. Head Neck. 2020;42(8):1699\u2013712. https:\/\/doi.org\/10.1002\/hed.26089.","journal-title":"Head Neck"},{"issue":"1","key":"349_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40364-021-00292-x","volume":"9","author":"CT Viet","year":"2021","unstructured":"Viet CT, Yu G, Asam K, Thomas CM, Yoon AJ, Wongworawat YC, et al. The REASON Score: An Epigenetic and Clinicopathologic Score to Predict Risk of Poor Survival in Patients with Early Stage Oral Squamous Cell Carcinoma. Biomark Res. 2021;9(1):9. https:\/\/doi.org\/10.1186\/s40364-021-00292-x.","journal-title":"Biomark Res"},{"issue":"11","key":"349_CR6","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1158\/1078-0432.CCR-11-0044","volume":"17","author":"GM Poage","year":"2011","unstructured":"Poage GM, Houseman EA, Christensen BC, Butler RA, Avissar-Whiting M, McClean MD, et al. Global hypomethylation identifies loci targeted for hypermethylation in head and neck cancer. Clin Cancer Res. 2011;17(11):3579\u201389. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0044.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"349_CR7","first-page":"844","volume":"35","author":"CT Viet","year":"2007","unstructured":"Viet CT, Jordan RC, Schmidt BL. DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer. J Calif Dent Assoc. 2007;35(12):844\u20139.","journal-title":"J Calif Dent Assoc"},{"issue":"12","key":"349_CR8","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1158\/1055-9965.EPI-08-0507","volume":"17","author":"CT Viet","year":"2008","unstructured":"Viet CT, Schmidt BL. Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol Biomark Prev. 2008;17(12):3603\u201311. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0507.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"7","key":"349_CR9","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.4161\/epi.29025","volume":"9","author":"R Guerrero-Preston","year":"2014","unstructured":"Guerrero-Preston R, Michailidi C, Marchionni L, Pickering CR, Frederick MJ, Myers JN, et al. Key tumor suppressor genes inactivated by \"greater promoter\" methylation and somatic mutations in head and neck cancer. Epigenetics. 2014;9(7):1031\u201346. https:\/\/doi.org\/10.4161\/epi.29025.","journal-title":"Epigenetics"},{"issue":"1","key":"349_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(05)70540-4","volume":"7","author":"PK Ha","year":"2006","unstructured":"Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol. 2006;7(1):77\u201382. https:\/\/doi.org\/10.1016\/S1470-2045(05)70540-4.","journal-title":"Lancet Oncol"},{"issue":"5","key":"349_CR11","first-page":"551","volume":"10","author":"MJ Huang","year":"2002","unstructured":"Huang MJ, Yeh KT, Shih HC, Wang YF, Lin TH, Chang JY, et al. The correlation between CpG methylation and protein expression of P16 in oral squamous cell carcinomas. Int J Mol Med. 2002;10(5):551\u20134.","journal-title":"Int J Mol Med"},{"issue":"8","key":"349_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.bjoms.2007.04.015","volume":"45","author":"RJ Shaw","year":"2007","unstructured":"Shaw RJ, Hall GL, Woolgar JA, Lowe D, Rogers SN, Field JK, et al. Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2007;45(8):617\u201322. https:\/\/doi.org\/10.1016\/j.bjoms.2007.04.015.","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"4","key":"349_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/sj.bjc.6602972","volume":"94","author":"RJ Shaw","year":"2006","unstructured":"Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, et al. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer. 2006;94(4):561\u20138. https:\/\/doi.org\/10.1038\/sj.bjc.6602972.","journal-title":"Br J Cancer"},{"issue":"1","key":"349_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/jmg.40.1.25","volume":"40","author":"DJ Smiraglia","year":"2003","unstructured":"Smiraglia DJ, Smith LT, Lang JC, Rush LJ, Dai Z, Schuller DE, et al. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). J Med Genet. 2003;40(1):25\u201333. https:\/\/doi.org\/10.1136\/jmg.40.1.25.","journal-title":"J Med Genet"},{"issue":"6C","key":"349_CR15","first-page":"3971","volume":"22","author":"KT Yeh","year":"2002","unstructured":"Yeh KT, Shih MC, Lin TH, Chen JC, Chang JY, Kao CF, et al. The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma. Anticancer Res. 2002;22(6C):3971\u20135.","journal-title":"Anticancer Res"},{"issue":"3","key":"349_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/15592294.2015.1006506","volume":"10","author":"YF Li","year":"2015","unstructured":"Li YF, Hsiao YH, Lai YH, Chen YC, Chen YJ, Chou JL, et al. DNA methylation profiles and biomarkers of oral squamous cell carcinoma. Epigenetics. 2015;10(3):229\u201336. https:\/\/doi.org\/10.1080\/15592294.2015.1006506.","journal-title":"Epigenetics"},{"issue":"8","key":"349_CR17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ijom.2018.01.020","volume":"47","author":"N Eljabo","year":"2018","unstructured":"Eljabo N, Nikolic N, Carkic J, Jelovac D, Lazarevic M, Tanic N, et al. Genetic and epigenetic alterations in the tumour, tumour margins, and normal buccal mucosa of patients with oral cancer. Int J Oral Maxillofac Surg. 2018;47(8):976\u201382. https:\/\/doi.org\/10.1016\/j.ijom.2018.01.020.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"349_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13072-020-00372-6","volume":"13","author":"C Shu","year":"2020","unstructured":"Shu C, Zhang X, Aouizerat BE, Xu K. Comparison of methylation capture sequencing and Infinium MethylationEPIC array in peripheral blood mononuclear cells. Epigenetics Chromatin. 2020;13(1):51. https:\/\/doi.org\/10.1186\/s13072-020-00372-6.","journal-title":"Epigenetics Chromatin"},{"issue":"5","key":"349_CR19","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hed.26624","volume":"43","author":"DB Gissi","year":"2021","unstructured":"Gissi DB, Morandi L, Colella G, De Luca R, Campisi G, Mauceri R, et al. Clinical validation of 13-gene DNA methylation analysis in oral brushing samples for detection of oral carcinoma: Italian multicenter study. Head Neck. 2021;43(5):1563\u201373. https:\/\/doi.org\/10.1002\/hed.26624.","journal-title":"Head Neck"},{"issue":"1","key":"349_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13148-017-0386-7","volume":"9","author":"L Morandi","year":"2017","unstructured":"Morandi L, Gissi D, Tarsitano A, Asioli S, Gabusi A, Marchetti C, et al. CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel. Clin Epigenetics. 2017;9(1):85. https:\/\/doi.org\/10.1186\/s13148-017-0386-7.","journal-title":"Clin Epigenetics"},{"issue":"18","key":"349_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ijms21186691","volume":"21","author":"DB Gissi","year":"2020","unstructured":"Gissi DB, Fabbri VP, Gabusi A, Lenzi J, Morandi L, Melotti S, et al. Pre-Operative Evaluation of DNA Methylation Profile in Oral Squamous Cell Carcinoma Can Predict Tumor Aggressive Potential. Int J Mol Sci. 2020;21(18):21. https:\/\/doi.org\/10.3390\/ijms21186691.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"349_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3322\/caac.21389","volume":"67","author":"WM Lydiatt","year":"2017","unstructured":"Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and neck cancers-major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122\u201337. https:\/\/doi.org\/10.3322\/caac.21389.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"349_CR23","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1158\/1078-0432.CCR-07-4534","volume":"14","author":"JM Taylor","year":"2008","unstructured":"Taylor JM, Ankerst DP, Andridge RR. Validation of biomarker-based risk prediction models. Clin Cancer Res. 2008;14(19):5977\u201383. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4534.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"349_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/15592294.2015.1132136","volume":"11","author":"AL Teh","year":"2016","unstructured":"Teh AL, Pan H, Lin X, Lim YI, Patro CP, Cheong CY, et al. Comparison of methyl-capture sequencing vs. Infinium 450K methylation array for methylome analysis in clinical samples. Epigenetics. 2016;11(1):36\u201348. https:\/\/doi.org\/10.1080\/15592294.2015.1132136.","journal-title":"Epigenetics"},{"issue":"1\u20132","key":"349_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/15592294.2019.1656159","volume":"15","author":"JA Heiss","year":"2020","unstructured":"Heiss JA, Brennan KJ, Baccarelli AA, Tellez-Rojo MM, Estrada-Gutierrez G, Wright RO, et al. Battle of epigenetic proportions: comparing Illumina's EPIC methylation microarrays and TruSeq targeted bisulfite sequencing. Epigenetics. 2020;15(1\u20132):174\u201382. https:\/\/doi.org\/10.1080\/15592294.2019.1656159.","journal-title":"Epigenetics"},{"issue":"1","key":"349_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/14737159.2017.1404906","volume":"18","author":"L Arantes","year":"2018","unstructured":"Arantes L, De Carvalho AC, Melendez ME, Lopes Carvalho A. Serum, plasma and saliva biomarkers for head and neck cancer. Expert Rev Mol Diagn. 2018;18(1):85\u2013112. https:\/\/doi.org\/10.1080\/14737159.2017.1404906.","journal-title":"Expert Rev Mol Diagn"},{"issue":"4","key":"349_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/15592294.2018.1461295","volume":"13","author":"S Nishitani","year":"2018","unstructured":"Nishitani S, Parets SE, Haas BW, Smith AK. DNA methylation analysis from saliva samples for epidemiological studies. Epigenetics. 2018;13(4):352\u201362. https:\/\/doi.org\/10.1080\/15592294.2018.1461295.","journal-title":"Epigenetics"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-021-00349-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-021-00349-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-021-00349-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T04:46:06Z","timestamp":1644900366000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-021-00349-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1186\/s40364-021-00349-x","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"7 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval was obtained to collect biological samples and create the de-identified patient databases at each respective institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}